BurTech Acquisition Raises Blaize Purchase Price, Strikes Lock-up on Convertible Notes | DealFlows SPAC News
Summary
Under terms of the deal, 4D pharma would receive the $14.6 million cash held by Longevity. In addition, 4D pharma would gain the proceeds of warrants to purchase Longevity shares worth up to $23 million.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected